Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 8, 2016, Pages 1462-1469

  Song, Haizhao ^a,b   Chu, Qiang ^a   Yan, Fujie ^a   Yang, Yunyun ^a   Han, Wen ^a   Zheng, Xiaodong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

betacyanins; gut microbiota; hepatic steatosis; insulin resistance; obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETACYANIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RIBOSOME RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; ANTIOBESITY AGENT; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; GLUCOSE BLOOD LEVEL; INSULIN; LIPID;

AKKERMANSIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEROIDETES; BROWN ADIPOCYTE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SCREENING; FATTY LIVER; FIRMICUTES; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYLOCEREUS; HYLOCEREUS POLYRHIZUS; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; LIVER PROTECTION; LOW FAT DIET; MALE; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PHYLUM; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; PROTEOBACTERIA; RNA SEQUENCE; TRIACYLGLYCEROL BLOOD LEVEL; VERRUCOMICROBIA; WEIGHT GAIN; WHITE ADIPOCYTE; ANIMAL; BLOOD; C57BL MOUSE; CACTACEAE; CHEMISTRY; CLASSIFICATION; DISEASE MODEL; DRUG EFFECTS; FRUIT; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; INTRAABDOMINAL FAT; ISOLATION AND PURIFICATION; LIVER; MEDICINAL PLANT; METABOLISM; MICROBIOLOGY; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; TIME FACTOR;

ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; BACTEROIDETES; BETACYANINS; BIOMARKERS; BLOOD GLUCOSE; CACTACEAE; CYTOKINES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FIRMICUTES; FRUIT; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPIDS; LIVER; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHYTOTHERAPY; PLANTS, MEDICINAL; TIME FACTORS; WEIGHT GAIN;

EID: 84984598130     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13278     Document Type: Article

References (42)

1. Popkin BM, Kim S, Rusev ER, Du S, Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes. Rev. 2006; 7: 271–93.
2. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Cl Ga. 2013; 27: 73–83.
3. Derosa G, Maffioli P. Anti-obesity drugs: a review about their effects and their safety. Expert Opin. Drug Saf. 2012; 11: 459–71.
4. Xu J, Mahowald MA, Ley RE et al. Evolution of symbiotic bacteria in the distal human intestine. Plos Biol. 2007; 5: 1574–86.
5. Xu J, Gordon JI. Honor thy symbionts. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 10452–9.
6. Kovatcheva-Datchary P, Arora T. Nutrition, the gut microbiome and the metabolic syndrome. Best Pract Res Cl Ga. 2013; 27: 59–72.
7. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA et al. High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity. Gastroenterology 2009; 137: 1716–24.
8. Cani PD, Neyrinck AM, Fava F et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374–83.
9. Cani PD, Bibiloni R, Knauf C et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470–81.
10. Everard A, Lazarevic V, Derrien M et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60: 2775–86.
11. Yusof RM, Akhiruddin MA. Hypocholesterolemic effect of fermented red pitaya (hylocereus polyrhizus) juice in diet-induced Hypercholesterolemic Rats. Ann. Nutr. Metab. 2009; 55: 92–101.
12. Wybraniec S, Mizrahi Y. Generation of decarboxylated and dehydrogenated betacyanins in thermally treated purified fruit extract from purple pitaya (Hylocereus polyrhizus) monitored by LC-MS/MS. J Agr Food Chem. 2005; 53: 6704–12.
13. Han JY, Ma DS, Zhang M, Yang XL, Tan DH. Natural Antioxidant Betanin Protects Rats from Paraquat-Induced Acute Lung Injury Interstitial Pneumonia. Biomed Res Int. 2015; 2015: 1–9.
14. Wroblewska M, Juskiewicz J, Wiczkowski W. Physiological properties of beetroot crisps applied in standard and dyslipidaemic diets of rats. Lipids Health Dis. 2011; 10.
15. Omidizadeh A, Yusof RM, Roohinejad S, Ismail A, Abu Bakar MZ, Bekhit AEA. Anti-diabetic activity of red pitaya (Hylocereus polyrhizus) fruit. Rsc Adv. 2014; 4: 62978–86.
16. Abd Hadi N, Mohamad M, Rohin MAK, Mohd YR. Effects of red pitaya fruit (hylocereus polyrhizus) consumption on blood glucose level and lipidprofile in type 2 diabetic subjects. Borneo Science Journal. 2012; 31: 113–29.
17. Rohin MAK, Abd Hadi N, Mohd Yusof R, Rahmat A, Mansor SM, Ali AM. Hypocholesterolemic effect of red pitaya (Hylocereus sp.) on hypercholesterolemia induced rats. Int Food Res J. 2009; 16: 431–40.
18. Cai YZ, Sun M, Corke H. Identification and distribution of simple and acylated betacyanins in the amaranthaceae. J Agr Food Chem. 2001; 49: 1971–8.
19. Folch J, Lees M, Stanley GHS. A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues. J. Biol. Chem. 1957; 226: 497–509.
20. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–21.
21. Wybraniec S, Platzner I, Geresh S et al. Betacyanins from vine cactus Hylocereus polyrhizus. Phytochemistry 2001; 58: 1209–12.
22. Stintzing FC, Schieber A, Carle R. Betacyanins in fruits from red-purple pitaya, Hylocereus polyrhizus (Weber) Britton & Rose (vol 77, pg 101, 2001). Food Chem. 2002; 77: 101–6.
23. Svenson J, Smallfield BM, Joyce NI, Sanson CE, Perry NB. Betalains in red and yellow varieties of the Andean tuber crop ulluco (Ullucus tuberosus). J Agr Food Chem. 2008; 56: 7730–7.
24. Wybraniec S, Stalica P, Sporna A, Mizrahi Y. Profiles of betacyanins in epidermal layers of grafted and light-stressed cacti studied by LC-DAD-ESI-MS/MS. J Agr Food Chem. 2010; 58: 5347–54.
25. He JA, Giusti MM. Anthocyanins: Natural Colorants with Health-Promoting Properties. Annu Rev Food Sci T. 2010; 1: 163–87.
26. Munir KM, Chandrasekaran S, Gao F, Quon MJ. Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. Am J Physiol-Endoc M. 2013; 305: E679–E86.
27. Timmers S, Hesselink MKC, Schrauwen P. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Ann Ny Acad Sci. 2013; 1290: 83–9.
28. Zarjevski N, Cusin I, Vettor R, Rohnerjeanrenaud F, Jeanrenaud B. chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993; 133: 1753–8.
29. Brennan AM, Mantzoros CS. Drug Insight: the role of leptin in human physiology and pathophysiology - emerging clinical applications. Nat Clin Pract Endoc. 2006; 2: 318–27.
30. Charlton M. nonalcoholic fatty liver disease: A review of current understanding and future impact. Clin Gastroenterol H. 2004; 2: 1048–58.
31. Jang HH, Park MY, Kim HW et al. Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation. Nutr. Metab. 2012; 9.
32. Zhang S, Zheng LL, Dong DS et al. Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem. 2013; 141: 2108–16.
33. Song Y, Lee SJ, Jang SH et al. Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats. Nutrients 2014; 6: 2179–95.
34. Kruszynska YT, Olefsky JM. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J. Invest. Med. 1996; 44: 413–28.
35. DeFronzo RA. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth. J. Med. 1997; 50: 191–7.
36. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003; 148: 293–300.
37. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr. Diab. Rep. 2005; 5: 70–5.
38. Bastard JP, Maachi M, Lagathu C et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 2006; 17: 4–12.
39. Cancello R, Henegar C, Viguerie N et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277–86.
40. Backhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 15718–23.
41. Shin NR, Lee JC, Lee HY et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014; 63: 727–35.
42. Anhe FF, Roy D, Pilon G et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015; 64: 872–83.